September 17, 2021, RISE Innovation interview with Dr. Yan Leyfman, MD, hosted by Sal Peer of AI Exosphere.
Dr. Yan Leyfman has been recognized as one of the top international researchers in oncology by the American Society of Hematology and American Society of Clinical Oncology (ASCO). He has contributed to the development of several anti-cancer therapies that have recently entered clinical trials and new treatment recommendations of care. His successes have been recognized by the Goldwater Research Foundation, Sigma Xi, New York Times, and Harvard Medical School.
During the COVID-19 pandemic, he was recruited to join the Global COVID-19 Taskforce to serve as Director of the Immunology Division, which produced one of the first mechanisms for SARS-CoV-2 and COVI-Flu along with therapeutic interventions for both.
In June 2021, Dr. Leyfman presented the first mechanism to explain the interplay between cancer and COVID-19 at the 2021 ASCO Annual Meeting. His work has been published as the cover article in the journal, Shock, and in the textbook, Insights on a Post-COVID World. Over the past year, Yan was recognized as the 2020 Emerging International Scholar in Immunology & Immunotherapy, 2020 New York State & City Manhattan Hero for his community service and research contributions during the COVID-19 pandemic and by Memorial Sloan Kettering Cancer Center for research excellence.
Dr. Leyfman also has a passion for education, mentorship, and community service. He is a journal editor and mentor to medical students in redeveloping countries and gives talks about the latest innovations in medicine.
Sal and Yan discuss innovation, advancements in the medical field, medical research and more.
Premiering October 4th, 2021 on AI Exosphere’s YouTube channel and recorded for the RISE Innovation community.
To learn more about Dr. Yan Leyfman, MD – https://www.linkedin.com/in/yanleyfman/
To learn more about Sal Peer – https://www.salpeer.com
#interview #innovation #ai
